Brief report: Clinical use of zongertinib in patients with HER2 mutated NSCLC with brain metastases with or without leptomeningeal disease

JTO Clinical and Research Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles